SMTI (Sanara MedTech) FFO


SMTI Sanara MedTech Inc SMTI
72 GF Score
Price $23.19
GF Value $45.54
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Sanara MedTech FFO?

FFO (Funds from operations) only applies to REITs.

SMTI
72GF Score
Sanara MedTech Inc SMTI
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sanara MedTech (SMTI) Overvalued in 2026?

Based on GuruFocus' analysis, Sanara MedTech stock appears to be undervalued. The current stock price of $23.19 is trading 49.1% below its estimated GF Value™ of $45.54. GuruFocus considers Sanara MedTech to be Possible Value Trap.

Key valuation signals for SMTI:

  • FFO:
  • GF Value™: $45.54 vs. price of $23.19 (49.1% below fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the SMTI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sanara MedTech Business Description

Address 1200 Summit Avenue, Suite 414, Fort Worth, TX, USA, 76102
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
72GF Score

Get the complete analysis for SMTI

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.19
Price
$45.54
GF Value